Atrás
46
14
Rango del Día
$8.60
$8.83
Rango de 52 Semanas
$8.07
$15.48
Volumen
364,517
Promedio 50D / 200D
$9.02
/
$11.35
Cierre Anterior
$8.47
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 9.1 | 0.4 |
| P/B | 0.7 | 2.9 |
| ROE % | 9.6 | 3.8 |
| Net Margin % | 2.2 | 3.9 |
| Rev Growth 5Y % | 6.8 | 10.0 |
| D/E | 1.3 | 0.2 |
Precio Objetivo de Analistas
Hold
$14.14
+63.7%
Low: $12.00
High: $19.00
P/E Futuro
7.6
EPS Futuro
$1.14
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
6.6 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
$1.34
$1.07 – $1.58
|
7.2 B | 6 |
| FY2027 |
$1.26
$1.02 – $1.48
|
6.9 B | 6 |
| FY2026 |
$1.14
$1.03 – $1.37
|
6.6 B | 7 |
Puntos Clave
Revenue grew 6.75% annually over 5 years — modest growth
Earnings declined -35.43% over the past year
Generating 258.61M in free cash flow
P/E of 9.11 — trading at a low valuation
Cash machine — converts 190.42% of earnings into free cash flow
Capital efficient — spends only 3.35% of revenue on capex
Crecimiento
Revenue Growth (5Y)
6.75%
Revenue (1Y)6.01%
Earnings (1Y)-35.43%
FCF Growth (3Y)75.16%
Calidad
Return on Equity
9.64%
ROIC6.18%
Net Margin2.15%
Op. Margin5.15%
Seguridad
Debt / Equity
1.34
Current Ratio1.97
Interest Coverage5.90
Valoración
P/E Ratio
9.11
P/B Ratio0.73
EV/EBITDA8.58
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.01% | Revenue Growth (3Y) | 8.13% |
| Earnings Growth (1Y) | -35.43% | Earnings Growth (3Y) | 64.33% |
| Revenue Growth (5Y) | 6.75% | Earnings Growth (5Y) | -3.13% |
| Profitability | |||
| Revenue (TTM) | 6.32B | Net Income (TTM) | 135.81M |
| ROE | 9.64% | ROA | 2.57% |
| Gross Margin | 97.54% | Operating Margin | 5.15% |
| Net Margin | 2.15% | Free Cash Flow (TTM) | 258.61M |
| ROIC | 6.18% | FCF Growth (3Y) | 75.16% |
| Safety | |||
| Debt / Equity | 1.34 | Current Ratio | 1.97 |
| Interest Coverage | 5.90 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 9.11 | P/B Ratio | 0.73 |
| P/S Ratio | 0.20 | PEG Ratio | -0.23 |
| EV/EBITDA | 8.58 | Dividend Yield | 0.00% |
| Market Cap | 1.24B | Enterprise Value | 2.79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.32B | 5.97B | 5.41B | 5.13B | 4.87B |
| Net Income | 135.81M | 210.34M | 50.29M | 188.91M | 154.26M |
| EPS (Diluted) | 0.96 | 1.58 | 0.35 | 1.32 | 1.08 |
| Gross Profit | 6.17B | 4.93B | 5.27B | 4.17B | 3.94B |
| Operating Income | 325.58M | 405.76M | 229.50M | 217.03M | 436.56M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2018 |
|---|---|---|---|---|---|
| Total Assets | 5.29B | 4.96B | 5.10B | 4.86B | 2.75B |
| Total Liabilities | 3.61B | 3.43B | 4.02B | 3.81B | 2.03B |
| Shareholders' Equity | 1.69B | 1.13B | 670.90M | 639.05M | 331.65M |
| Total Debt | 2.26B | 2.28B | 2.40B | 2.39B | 1.26B |
| Cash & Equivalents | 709.60M | 556.79M | 437.58M | 456.12M | 59.66M |
| Current Assets | 2.06B | 1.83B | 1.62B | 1.41B | 860.42M |
| Current Liabilities | 1.05B | 945.42M | 994.10M | 808.60M | 624.83M |
Puntuaciones de Estrategias
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#491 of 1024
#507 of 616
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026
Entró
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026